Re: Trends in use of adjuvant multi-agent chemotherapy and tamoxifen for breast cancer in the United States: 1975-1999.
Jordan
V Craig
VC
Morrow
Monica
M
D000368:Aged; D000369:Aged, 80 and over; D018931:Antineoplastic Agents, Hormonal / Q000009:adverse effects / Q000627:therapeutic use*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy*; D002273:Carcinogens / Q000009:adverse effects*; D017024:Chemotherapy, Adjuvant / Q000639:trends*; D016889:Endometrial Neoplasms / Q000139:chemically induced; D020847:Estrogen Receptor Modulators / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008875:Middle Aged; D012189:Retrospective Studies; D013629:Tamoxifen / Q000009:adverse effects / Q000627:therapeutic use*; D006113:United Kingdom; D014481:United States
D018931:Antineoplastic Agents, Hormonal; D002273:Carcinogens; D020847:Estrogen Receptor Modulators; D013629:Tamoxifen